Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657771 · ClinicalTrials.gov registry record · NA
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
A NA study of Eosinophilic Esophagitis, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 3
- Study locations
NCT03657771: Completed NA study of Eosinophilic Esophagitis, sponsored by Nemours Children's Clinic.
NCT03657771 is a NA study of Eosinophilic Esophagitis that has completed, run by Nemours Children's Clinic. The registered enrollment target is 22 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657771, a NA study of Eosinophilic Esophagitis, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 3
- Study locations
Study Summary
Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)
Primary Outcome
Histologic change differences of maximum eosinophils per high power field
Conditions Studied
Interventions
- OTHER DED
- OTHER FREE
Study Locations (3)
Delaware
- Nemours/Alfred I DuPont Hospital for Children - Wilmington
Florida
- Nemours Children's Hospital - Orlando
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-11-12 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03657771 record still lists
NCT03657771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 2 interventions - of which DED is the first listed.
NCT03657771 reports a single indexed study location in Delaware, Florida, Washington.
Frequently Asked Questions
What is clinical trial NCT03657771 about?
NCT03657771 is a clinical study titled "A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis". Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)
What is the current status of trial NCT03657771?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-11-12. Estimated completion is 2023-12-31.
What conditions does trial NCT03657771 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis.
What interventions are being tested in trial NCT03657771?
The interventions under investigation include: DED (OTHER), FREE (OTHER).
Who is sponsoring clinical trial NCT03657771?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03657771 being conducted?
This trial has 3 study locations across Delaware, Florida, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03657771's enrollment target sits among peer trials
22 36th of 44 higher than 8 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
-
The Immune Directed Individualized Elimination Therapy (iDIET) Study
ACTIVE NOT RECRUITING · NA
-
Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
ACTIVE NOT RECRUITING · NA
-
Cytosponge and Dietary Therapy in EoE
COMPLETED · NA
-
Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI